Xvivo Perfusion AB Financial Overview
Xvivo Perfusion AB's market cap is currently $632.87M. The company's EPS TTM is $0.02785926; its P/E ratio is 223.86; Xvivo Perfusion AB is scheduled to report earnings on October 23, 2025, and the estimated EPS forecast is $0.07. See an overview of income statement, balance sheet, and cash flow financials.
